Poch E - Search Results

1

A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE.

Quintana LF, Guzmán B, Collado S, Clària J, Poch E. Quintana LF, et al. Among authors: poch e. Kidney Int. 2006 Feb;69(3):526-30. doi: 10.1038/sj.ki.5000147. Kidney Int. 2006. PMID: 16514435 Free article.

2

Increased levels of 12(S)-HETE in patients with essential hypertension.

González-Núñez D, Claria J, Rivera F, Poch E. González-Núñez D, et al. Among authors: poch e. Hypertension. 2001 Feb;37(2):334-8. doi: 10.1161/01.hyp.37.2.334. Hypertension. 2001. PMID: 11230294

3

Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis.

Fernández-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L. Fernández-Llama P, et al. Among authors: poch e. Kidney Int. 1998 Jun;53(6):1743-7. doi: 10.1046/j.1523-1755.1998.00946.x. Kidney Int. 1998. PMID: 9607207 Free article.

4

[Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].

Quintana LF, Lladó A, Butjosa M, Santamaría J, Torras A, Poch E. Quintana LF, et al. Among authors: poch e. Nefrologia. 2006;26(4):486-8. Nefrologia. 2006. PMID: 17058862 Free article. Spanish.

5

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.

Xipell M, Victoria I, Hoffmann V, Villarreal J, García-Herrera A, Reig O, Rodas L, Blasco M, Poch E, Mellado B, Quintana LF. Xipell M, et al. Among authors: poch e. Oncoimmunology. 2018 Mar 26;7(7):e1445952. doi: 10.1080/2162402X.2018.1445952. eCollection 2018. Oncoimmunology. 2018. PMID: 29900063 Free PMC article.

6

An update on tolvaptan for autosomal dominant polycystic kidney disease.

Poch E, Rodas L, Blasco M, Molina A, Quintana L. Poch E, et al. Drugs Today (Barc). 2018 Sep;54(9):519-533. doi: 10.1358/dot.2018.54.9.2776624. Drugs Today (Barc). 2018. PMID: 30303493 Review.

7

Intracellular calcium concentration and activation of the Na+/H+ exchanger in essential hypertension.

Poch E, Botey A, Gaya J, Darnell A, Rivera F, Revert L. Poch E, et al. Kidney Int. 1994 Apr;45(4):1037-43. doi: 10.1038/ki.1994.140. Kidney Int. 1994. PMID: 8007573 Free article.

8

Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension.

Gomez-Angelats E, de la Sierra A, Enjuto M, Sierra C, Oriola J, Francino A, Paré JC, Poch E, Coca A. Gomez-Angelats E, et al. Among authors: poch e. J Hum Hypertens. 2000 Jan;14(1):47-9. doi: 10.1038/sj.jhh.1000941. J Hum Hypertens. 2000. PMID: 10673731

9

Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage.

Fernández-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L. Fernández-Llama P, et al. Among authors: poch e. Am J Hypertens. 1998 Apr;11(4 Pt 1):439-44. doi: 10.1016/s0895-7061(97)00483-4. Am J Hypertens. 1998. PMID: 9607382

10

[Genetic polymorphisms of the renin-angiotensin system and essential hypertension].

Fernández-Llama P, Poch E, Oriola J, Botey A, de la Sierra A, Revert L, Rivera F, Darnell A. Fernández-Llama P, et al. Among authors: poch e. Med Clin (Barc). 1999 May 1;112(15):561-4. Med Clin (Barc). 1999. PMID: 10365380 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters